Securities Class Action
Securities fraud litigation history and active cases
In Litigation
0
Settlement
0
Closed
1
Total Settlement
$0
Bolt Biotherapeutics, Inc. (BOLT) Class Action Lawsuit (July 2024)
Closed3:24cv3985 • July 2, 2024
Class Period Start
February 5, 2021
Class Period End
May 14, 2024
PSLRA Deadline
September 3, 2024
Case Allegations
10b5
Statutes of Repose
Feb 5, 2024
Country
United States
Court
Federal Court
Docket History
Jan 17, 2025
Voluntary Dismissal (opens in a new tab)
The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.
Oct 3, 2024
Appointment of Lead Plaintiff (opens in a new tab)
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
Jul 2, 2024
First Filed Complaint (opens in a new tab)
A securities fraud class action complaint has been filed on behalf of certain investors in Bolt Biotherapeutics, Inc..